Logo image of ALPIX.PA

Pixium Vision SA (ALPIX.PA) Stock Fundamental Analysis

EPA:ALPIX - Euronext Paris - Matif - FR001400JX97 - Common Stock - Currency: EUR

0.3764  -0.04 (-10.17%)

Fundamental Rating

0

Taking everything into account, ALPIX scores 0 out of 10 in our fundamental rating. ALPIX was compared to 60 industry peers in the Health Care Equipment & Supplies industry. ALPIX may be in some trouble as it scores bad on both profitability and health. ALPIX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALPIX had negative earnings in the past year.
ALPIX had a negative operating cash flow in the past year.
ALPIX had negative earnings in each of the past 5 years.
In the past 5 years ALPIX always reported negative operating cash flow.
ALPIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALPIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

The Return On Assets of ALPIX (-154.03%) is worse than 98.11% of its industry peers.
Industry RankSector Rank
ROA -154.03%
ROE N/A
ROIC N/A
ROA(3y)-65.25%
ROA(5y)-66.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALPIX.PA Yearly ROA, ROE, ROICALPIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 200 -200

1.3 Margins

ALPIX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALPIX.PA Yearly Profit, Operating, Gross MarginsALPIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

ALPIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALPIX has more shares outstanding than it did 1 year ago.
ALPIX has a worse debt/assets ratio than last year.
ALPIX.PA Yearly Shares OutstandingALPIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
ALPIX.PA Yearly Total Debt VS Total AssetsALPIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -8.48, we must say that ALPIX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -8.48, ALPIX is doing worse than 92.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.48
ROIC/WACCN/A
WACC5.07%
ALPIX.PA Yearly LT Debt VS Equity VS FCFALPIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M 30M

2.3 Liquidity

ALPIX has a Current Ratio of 0.74. This is a bad value and indicates that ALPIX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.74, ALPIX is doing worse than 94.34% of the companies in the same industry.
A Quick Ratio of 0.74 indicates that ALPIX may have some problems paying its short term obligations.
ALPIX has a Quick ratio of 0.74. This is in the lower half of the industry: ALPIX underperforms 71.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
ALPIX.PA Yearly Current Assets VS Current LiabilitesALPIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.60% over the past year.
ALPIX shows a decrease in Revenue. In the last year, the revenue decreased by -4.23%.
The Revenue has been decreasing by -5.07% on average over the past years.
EPS 1Y (TTM)29.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.75%
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y3.13%
Revenue growth 5Y-5.07%
Sales Q2Q%-13.46%

3.2 Future

Based on estimates for the next years, ALPIX will show a very strong growth in Earnings Per Share. The EPS will grow by 24.50% on average per year.
Based on estimates for the next years, ALPIX will show a very negative growth in Revenue. The Revenue will decrease by -35.08% on average per year.
EPS Next Y55%
EPS Next 2Y24.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.17%
Revenue Next 2Y-35.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALPIX.PA Yearly Revenue VS EstimatesALPIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALPIX.PA Yearly EPS VS EstimatesALPIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALPIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALPIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALPIX.PA Price Earnings VS Forward Price EarningsALPIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALPIX.PA Per share dataALPIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

ALPIX's earnings are expected to grow with 24.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.5%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALPIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Pixium Vision SA

EPA:ALPIX (1/30/2024, 7:00:00 PM)

0.3764

-0.04 (-10.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.53M
Analysts86.67
Price Target45.9 (12094.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)37.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.85
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.99
EYN/A
EPS(NY)-4.63
Fwd EYN/A
FCF(TTM)-2.03
FCFYN/A
OCF(TTM)-2.01
OCFYN/A
SpS0.44
BVpS-1.52
TBVpS-1.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -154.03%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-65.25%
ROA(5y)-66.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15%
Cap/Sales 3.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z -8.48
F-Score3
WACC5.07%
ROIC/WACCN/A
Cap/Depr(3y)13%
Cap/Depr(5y)9.22%
Cap/Sales(3y)3.48%
Cap/Sales(5y)2.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.75%
EPS Next Y55%
EPS Next 2Y24.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.23%
Revenue growth 3Y3.13%
Revenue growth 5Y-5.07%
Sales Q2Q%-13.46%
Revenue Next Year-5.17%
Revenue Next 2Y-35.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-30.64%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.82%
OCF growth 3YN/A
OCF growth 5YN/A